Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipender Gill

Showing results (121-130 of 325) with videos related to

Pageof 33
Sort By:
BMJ (Clinical Research Ed.)|December 12, 2023
A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation studyBenjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, et al.
Annual Review of Pharmacology and Toxicology|July 14, 2023
Addressing Ancestry and Sex Bias in PharmacogenomicsManuel Corpas, Moneeza K Siddiqui, Opeyemi Soremekun, et al.
Journal of the American Heart Association|November 3, 2021
Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization StudyVille Karhunen, Mark K Bakker, Ynte M Ruigrok, et al.
Biomedicines|February 24, 2024
Cerebrospinal and Brain Proteins Implicated in Neuropsychiatric and Risk Factor Traits: Evidence from Mendelian RandomizationRoxane de La Harpe, Loukas Zagkos, Dipender Gill, et al.
BMC Research Notes|January 17, 2024
MRSamePopTest: introducing a simple falsification test for the two-sample mendelian randomisation 'same population' assumptionBenjamin Woolf, Amy Mason, Loukas Zagkos, et al.
American Journal of Epidemiology|June 21, 2024
Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target mendelian randomizationBenjamin Woolf, Héléne T Cronjé, Loukas Zagkos, et al.
International Journal of Cardiology. Heart & Vasculature|July 3, 2025
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target Mendelian randomization studyJonathan L Ciofani, Daniel Han, Benjamin Woolf, et al.
Stroke|June 11, 2024
Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization StudyOpeyemi Soremekun, Thobeka Mhlongwe, Gloria Kirabo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 8, 2016
A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological RecoveryDipender Gill, Thomas Cox, Adarsh Aravind, et al.
Neurology|November 30, 2021
Cardiovascular Risk Factors and MRI Markers of Cerebral Small Vessel Disease: A Mendelian Randomization StudyVictoria Taylor-Bateman, Dipender Gill, Marios K Georgakis, et al.
Pageof 33

Showing results (121-130 of 325) with videos related to

Sort By:
Pageof 33
BMJ (Clinical Research Ed.)|December 12, 2023
A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation studyBenjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, et al.
Annual Review of Pharmacology and Toxicology|July 14, 2023
Addressing Ancestry and Sex Bias in PharmacogenomicsManuel Corpas, Moneeza K Siddiqui, Opeyemi Soremekun, et al.
Journal of the American Heart Association|November 3, 2021
Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization StudyVille Karhunen, Mark K Bakker, Ynte M Ruigrok, et al.
Biomedicines|February 24, 2024
Cerebrospinal and Brain Proteins Implicated in Neuropsychiatric and Risk Factor Traits: Evidence from Mendelian RandomizationRoxane de La Harpe, Loukas Zagkos, Dipender Gill, et al.
BMC Research Notes|January 17, 2024
MRSamePopTest: introducing a simple falsification test for the two-sample mendelian randomisation 'same population' assumptionBenjamin Woolf, Amy Mason, Loukas Zagkos, et al.
American Journal of Epidemiology|June 21, 2024
Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target mendelian randomizationBenjamin Woolf, Héléne T Cronjé, Loukas Zagkos, et al.
International Journal of Cardiology. Heart & Vasculature|July 3, 2025
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target Mendelian randomization studyJonathan L Ciofani, Daniel Han, Benjamin Woolf, et al.
Stroke|June 11, 2024
Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization StudyOpeyemi Soremekun, Thobeka Mhlongwe, Gloria Kirabo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 8, 2016
A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological RecoveryDipender Gill, Thomas Cox, Adarsh Aravind, et al.
Neurology|November 30, 2021
Cardiovascular Risk Factors and MRI Markers of Cerebral Small Vessel Disease: A Mendelian Randomization StudyVictoria Taylor-Bateman, Dipender Gill, Marios K Georgakis, et al.
Pageof 33